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ABSTRACT
Advances in data collection in radiation therapy have led to an
abundance of opportunities for applying data mining and machine
learning techniques to promote new data-driven insights. In light of
these advances, supporting collaboration between machine learning
experts and clinicians is important for facilitating better development
and adoption of these models. Although many medical use-cases
rely on spatial data, where understanding and visualizing the un-
derlying structure of the data is important, little is known about the
interpretability of spatial clustering results by clinical audiences.
In this work, we reflect on the design of visualizations for explain-
ing novel approaches to clustering complex anatomical data from
head and neck cancer patients. These visualizations were developed,
through participatory design, for clinical audiences during a multi-
year collaboration with radiation oncologists and statisticians. We
distill this collaboration into a set of lessons learned for creating
visual and explainable spatial clustering for clinical users.
Keywords: Data Clustering and Aggregation, Life Sciences, Col-
laboration, Mixed Initiative Human-Machine Analysis, Guidelines
1 INTRODUCTION
One of the most important applications of machine learning (ML)
techniques to oncological healthcare is patient stratification. Stratifi-
cation is the division of a patient population (group) into subgroups,
or ”strata”. Each strata represents a particular section of that patient
population. The strata are typically correlated with specific demo-
graphic or disease traits, and specific outcomes including survival or
side effects in response to specific treatments. The nature of patient
stratification makes it well suited for clustering—an unsupervised
data mining technique that groups patients based on some measure
of distance between them. When the distance measure and clustering
algorithm is well chosen, clustering can generate novel insights and
help discover previously undiscovered structure in the data.
Oncological data is often tied to a patient’s anatomy, which com-
plicates the construction of a similarity measure between patients
and the selection of a clustering algorithm. In cancer patients, the
spatial information of the tumor and surrounding anatomy is vital in
deciding optimal treatment and forecasting patient endpoints. Thus,
understanding the underlying spatial structure of the data during
the clustering process is important. Despite a widespread interest
in sophisticated clustering techniques for patient stratification, the
adoption of clustering in oncology is stifled by the difficulty in
understanding the inner workings of spatially-informed clustering.
In this work, we examine a participatory design of explanatory
visual encodings born out of a long-term collaboration between
oncology, data mining, and data visualization practitioners perform-
ing analysis on a cohort of head and neck cancer patients [23, 29].
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Specifically, this work looks at interpreting clusters of stratified head
and neck cancer patients based on secondary disease spread to the
lymph nodes, with the goal of helping clinical users understand the
strata and use them to help predict the toxicity outcome of disease
treatment. We reflect on the process of creating domain-specific vi-
sual encodings through participatory design to help ”bridge the gap”
between the data experts and healthcare experts [15]. We further
explore obstacles and successes when creating visual encodings for
interpreting data mining techniques, and for communicating with
oncology experts with limited background in both visualization and
in artificial intelligence.
2 RELATED WORK
Cluster Explainability Interpretation and visualization of clusters
is a common analysis task tightly integrated with dimensionality re-
duction in general, but is less understood than traditional explainable
AI (XAI) approaches, which are generally focused on supervised
learning. A task analysis of 10 data analysts [3] included 3 tasks
related to clusters: verifying clusters, naming clusters, and matching
clusters to existing classes. General methods of cluster visualizing
have typically been linked to low-dimensionality embedding, where
classes are shown plotted in a 2 or 3 dimensional space, and cluster-
membership is shown on top of the data in the lower-dimension
space [1,11,31]. Hierarchical clustering methods, where clusters are
iteratively created at different levels of granularity, have commonly
been visualized as dendrograms. When dimensionality reduction
isn’t appropriate, general methods of multivariate data visualization
are used, such as parallel coordinate plots [8] or specialized glyph
encodings [5]. Other systems synthesize existing methods to support
visual steering and clustering for scientists [6, 7, 25]. While some
recent work has dealt with clustering ensemble geospatial data [19],
we are not aware of any methods that deal explicitly with clustering
anatomical or 3-d data as in this work.
Vis in Healthcare Visualization approaches to healthcare problems
often focus on supporting data exploration, rather than understanding
predictive models [2, 4, 17]. Certain systems for model exploration
have been developed to aid in the development of regression models
based on the workflows of biostatisticians [10, 28]. Other systems
have applied visualization for clustering cancer data [25], and pre-
dicting infection spread in hospital wards [26]. For spatial data,
Grossmann et al. [13] incorporated methods for visualizing clusters
based on bladder shape to support a retrospective study on prostate
cancer patients. Some works have attempted to identify design con-
siderations when working with domain experts in healthcare [20,27].
However, with the exception of Raidou et al. [27], most of these
considerations do not apply to clustering or spatial data, and are
largely focused on analytics and electronic health record data. As
a result, there is a dearth of papers discussing how to approach
unsupervised XAI models to reach clinical audiences.
3 BACKGROUND
In many cancer patients, tumors metastasize into the lymphatic
system, causing lymph nodes to become ”involved”—affected by
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secondary nodal tumors. The lymphatic system forms a complex
chain of lymph nodes, and these secondary tumors spread along
these chains to adjacent regions stochastically. Affected lymph
nodes are a long-established factor in determining patient outcomes
in head and neck cancer [16]. Current predictive systems use a
staging system based on the size and number of nodal tumors, but
miss more nuanced predictions about how the different patterns
of nodal spread may affect toxicity outcomes [14, 35]. No prior
machine learning methods correctly handle this type of spatial data,
due to a lack of spatial similarity measures [12, 18].
Our data comes from a cohort of 582 head and neck cancer pa-
tients collected retrospectively from the MD Anderson Cancer Cen-
ter. All patients survived for at least 6 months after treatment. Data
was collected on the presence of 2 severe side effects: feeding tube
dependency, and aspiration - fluid in the lungs that requires removal.
We mainly consider the presence of either of these side effects, which
we define as as radiation-associated dysphagia (RAD) [9]. The data
also encodes the disease spread to 9 connected regions (denoted as
levels 1A-6) on each side of the head, along with the disconnected
retropharyngeal lymph node (RP or RPN). Many patients in this
cohort had unique patterns of disease spread to the lymph nodes.
The project consisted of 2 phases with distinct design require-
ments. In phase 1 (model development), we worked alongside six
domain experts in radiation oncology, and two data analysts with
data mining and biostatistics backgrounds, over four years. During
this time we developed, validated, and deployed an anatomically-
informed patient stratification method based on each patient’s pat-
terns of diseased lymph nodes [18]. To demonstrate the important
role of spatiality, the stratification used only anatomical features. We
met with representatives from this group up to three times per week
via teleconferencing, as well as in quarterly face to face meetings. In
phase 2 (model dissemination), our results needed to be analyzed and
delivered to the larger radiation oncology community. In this stage,
we received feedback from three additional radiation oncologists
and two bioinformaticians with expertise in head and neck cancer.
The final stratification approach is available to clinicians through an
open-source interface [23]. Below, we reflect on the design process,
which focused on an activity-centered design paradigm [22], along
with feedback from the domain experts.
4 MODEL DEVELOPMENT PHASE
Figure 1: (A) Lymph nodes overlaid over a diagram of the neck. (B)
Example graphs of diseased nodes for 2 individual patients (datapoint
representation). (C) Example consensus graph for 1 cluster (cluster
representation). The top-right graph shows disease spread with 66+%
of patients on the right nodes in 1B, 2A, 2B, and 3, and disease in
1-33% of patients in right node 4. The bottom-right graph similarly
indicates involvement of >66% and <33% of patients in left nodes 4
and 3, respectively.
Figure 2: Part of an augmented dendrogram of lymph node clusters
(clusters 1-3 not shown; the full dendrogram is available in Luciani
et al. Leaves of the tree are smaller clusters that merge at higher
levels according to the agglomerative clustering algorithm. Clusters
are id-ed by colors in the graph. Clusters are further augmented with
breakdowns of relevant clinical covariates of interest (F.T.: Feeding
Tube; Asp.: Aspiration).
In phase 1, we worked to identify a meaningful, anatomically-
informed distance measure between patients, as well as an appro-
priate method of clustering the patients. We developed an approach
in which each side of the head was treated as a graph. Nodes in
this graph corresponded with regions in the head that aligned with
those used in existing oncology literature, and regions that were
anatomically adjacent in the head were connected in the graph as an
edge. Each patient was treated as two sub-graphs, one for each side
of the head, containing only the nodes with nodal tumors. A distance
measure based on these graphs then needed to be identified, along-
side a clustering technique that led to meaningful clusters (activity
2). Clustering was performed using only the spatial disease spread
captured by the graph model. Because identifying relevant struc-
tures in oncological data is nontrivial, defining this methodology
required iterative experimentation with different features, clustering
techniques, numbers of clusters, and other parameters [30]. We
identified the following activities that required visual support:
1. Identify and analyze the relevant spatial data features underly-
ing one datapoint (i.e. patient).
2. Analyze the effects of different spatial similarity measures on
clustering (i.e. why two patients are considered to be similar
under a specific measure).
3. Analyze the representative patterns and pattern variation within
each cluster.
Datapoint Representation The first design followed a graph
metaphor to encode the diseased regions for each patient (activity
1). A compact graph that followed an anatomical map of lymph
node chains for half the head (because the problem is symmetric)
was used as a template for each patient (Figure 1-A), based on ideas
from biological network visualization [24, 32]. For each patient,
two envelopes were drawn over their diseased nodes. Green and
purple envelopes were used for the left and right side of the head,
respectively. Areas where envelopes overlap are shown in blue and
denote regions where tumors occur on both sides of the head, which
are of particular interest to oncologists (Figure 1-B).
Figure 3: (A) Cluster conditionals. (Top-left) Map of the regions in the
neck. Color indicates when the decision tree classified a patient into
the cluster based on if the region had no disease (pale red), tumors
in one side of the head (red), both sides of the head (dark red), or
a combination of two options. (Bottom-left) Radar chart showing the
percentage of patients in the cluster with nodal tumors in a given
region. Color indicates the presence of tumors in exactly one (pale
red) or two (dark red) sides of the head. (B) Second iteration of cluster
conditionals. (Top-right) Membership diagram showing the regions
in the head. Color indicates when all (red), a subset of (yellow), or
none of (blue) the patients in a cluster had nodal tumors in a region.
(Bottom-right) Decision-tree based diagram. Colors indicate when a
decision tree classified a patient into that cluster.
This design allowed for a compact representation of a complex
spatial feature space, while following the mathematical intuition
behind different distance measures. These graphs were incorporated
into an interface that shows patients and compares them to their most
similar matches. The compact representation was useful in identi-
fying the spatial features of each datapoint, as well as interpreting
distance between patients.
Cluster Representation In a first attempt to characterize each
cluster, we selected a representative patient for each cluster: i.e., the
patient closest to the cluster centroid (activity 3). The representative
patient, however, did not capture any intra-cluster variability. Sub-
sequently, we created a new representative encoding by placing the
most commonly affected nodes for a cluster in a ”consensus” graph.
Nodes where 23 of the patients in that cluster had nodal tumors were
outlined in envelopes. However, in this new representation it was
unclear why certain clusters were not merged. In a third iteration,
we added a different marker (squares) for nodes where less than 23 of
the patients in that cluster, but at least one patient had nodal tumors
(Figure 1-C). We used shape, rather than color, because hue already
encoded disease laterality, and further intensity variation was not
legible given the small scale.
However, at small scale, the markers and colors for multiple clus-
ters became hard to distinguish. Additionally, outside clinicians and
bioinformaticians mis-interpreted the third encoding as representing
only one patient in that cluster, and in one case, as clusters contain-
ing identical patients. In the fourth design, two stacked graphs were
used for each side of the head for each cluster, and visual scaffold-
ing [21] was used to explain the progression from a single datapoint
representation to the consensus graph. The consensus graphs were
placed within dendrograms, which showed the consensus graphs
of smaller component clusters within each larger cluster of interest
(Figure 2). To further clarify the hierarchical clustering process,
we added explicit color-coding of the dendrograms, with labels and
Figure 4: Designs for two high-risk cluster conditionals. (Top) Spatial
heatmaps showing the portion of patients with nodal tumors in each
region for at least one (left) or both (right) sides of the head. Regions
most informative in determining cluster membership are outlined in a
thick dark border. (Bottom) Radar charts showing the percentage of
patients within the cluster with a given toxicity outcome (FT/RAD/AS),
and those within an existing risk-staging group (T1/T4/N2a/N2b/N2c).
colors showing the cluster names and tracing the merging process, as
well as small statistics tables showing the patient toxicity outcomes
within each larger cluster.
5 CLINICAL MODEL DISSEMINATION PHASE
In the second phase, our results needed to be able to reach their
intended audience: clinical radiation oncologists. While the method-
ological development was concerned with the clinical validity of
the analysis, clinical readers are more concerned with significance
of the results, and place more importance on feasibility, trust in the
underlying covariates, and the implications of the results [33, 34],
rather than the methodology used, which had already been peer-
reviewed [18]. In this phase, we used four clusters to align with
existing staging systems, and the clustering still only considered
spatial disease spread. In order to effectively communicate results,
we identified the following activities to support:
1. Describe patient clusters from an anatomical perspective.
2. Identify each cluster’s underlying structure.
3. Connect structural cluster differences to clinical covariates.
4. Explain plausible causal relationships between the clusters and
correlated patient outcomes.
Cluster Conditionals The first design relied on two synergistic
encodings for each cluster. The first encoding expanded on the origi-
nal anatomical diagram to show the most discriminative features in
each cluster (conditionals). To do this, a decision tree was trained
on the cohort to predict cluster membership with 100% accuracy
using the number of sides of the head with a nodal tumor in each
region of the head and neck, which could be 0 (no disease), 1 (unilat-
eral disease), or 2 (bilateral disease). Because experts who had not
participated in the methodology design process had trouble under-
standing the graph-based encoding, the set of variables considered
sufficient to any patient in the training data into a given cluster was
then encoded into an anatomical region diagram of one side of the
neck (Figure 3-A). By focusing on the regions that the decision tree
considered, the diagram highlighted the regions that best identified
the key differences between clusters, while omitting regions with
commonalities between then, in order to support activities 2 and 3.
The second encoding was a radar plot of the percentage of people in
a cluster with either unilateral or bilateral disease spread in a given
region of the neck. This representation allowed for a more detailed
view of the overall distribution of tumors in each cluster (activity 1).
The initial cluster visualization design using trees was found to
intuitively make sense to clinical collaborators. However, they had
difficulty understanding the underlying explanation of the diagrams
and how they were generated within the space of a figure caption,
as they had limited experience with decision trees. Collaborators
incorrectly assumed that all combinations of nodal disease in the
diagrams were shared between all patients in a given cluster. Ad-
ditionally, our collaborators pointed out that while the one-sided
diagram of the neck was common for surgical applications, radiation
oncologists often visualized the neck in terms of a front view that
included both sides of the head simultaneously.
In the second design (Figure 3-B), each cluster is encoded using
a frontal view anatomical diagram. A red-yellow-blue categorical
color scheme was used to mark which regions were diseased in all
patients, some patients, or no patients within the cluster, respectively,
following the original intuition of our collaborators. An additional
anatomical diagram based on the decision tree was included for each
cluster below the membership diagrams. Since the new diagram
included both sides of the head, color was used to show when the
decision tree split the cluster based on the presence of disease (red),
or absence of disease (gray) in a given region, while white regions
were not considered in the model.
Cluster Membership The conditional designs were better-
received by the clinicians, but difficulties in understanding the col-
ormap and the lack of detail in the cluster membership made it
challenging to correctly draw insights. To address these concerns,
we designed a new heatmap diagram of the neck (Figure 4), which
used a sequential white-red color scheme to encode the number of
patients in a cluster with disease in a given region (activity 1). We
note that head and neck oncologists account for symmetry when
discussing similar patients, and thus a symmetric encoding was a
desired feature. A simplified decision tree was trained to identify
the regions that contained the most information about cluster mem-
bership, which were outlined with a dark border in the heatmaps
(activity 2). Additional labels were included, to indicate the left/right
sides of the diagram show unilateral vs. bilateral involvement, rather
than the literal left/right sides of the head.
To help indicate the relationship between the clusters and other
clinical data, covariates and outcomes that were the most interesting
to clinicians were included in a radar chart alongside the heatmaps
for each cluster. The inclusion of these data helped with the collabo-
rators’ ability to discuss potential relationships between the structure
of the clusters and correlated outcomes (activities 3 and 4).
6 DESIGN LESSONS
Through the course of these iterations, we have distilled design
lessons for interpretable clustering with spatial data.
L1. Use visual scaffolding based on users’ spatial background.
Spatial representations were, as expected, essential to understanding
the clustering. Furthermore, encodings were better received when
they mapped directly to the users’ model of the problem, particularly
when the users did not participate in the design. Using a graph-based
encoding for the patient lymph node chains allowed us to draw
parallels to graph theory, which was useful when testing similarity
measures that were based on graph matching methods. In contrast,
when designing for the wider oncology community, the encoding
best received was created by visually scaffolding the graph directly
onto an anatomical diagram of the neck from clinical literature.
L2. Incorporate visual details specific to the user’s activities. When
designing for the methodology development, we focused on develop-
ing the clustering algorithm and ensuring that the results were more
meaningful than existing methods. Placing the cluster visualizations
within a dendrogram allowed the users to scrutinize the inner work-
ings of the clusters at different scales. In contrast, clinicians were
more results-focused. Namely, their key interests focused on the
spatial structure underlying each cluster, how the clusters related to
outcomes and existing clinical categories, and if these correlations
could be explained in a way that was supported by clinical intuition.
Thus, the design benefited from incorporating anatomical details
and additional clinical covariates that were not considered when
designing the model.
L3. Show secondary variables and outcomes. Design iterations that
failed to include explicit labeling of results directly into the figure
led to confusion. In the initial dendrograms, viewers had trouble
connecting the clusters directly to other statistical analysis. For the
clinical figures, collaborators often assumed that there were direct
causal relationships between variables shown in the figure. In this
case, it was useful to include potential confounding variables, to
allow the readers to come up with alternative hypotheses.
L4. Design for both interactive and static visualization. In our
experience, we started out with interactive designs aiming to assist
a relatively small group of domain experts, who participated in the
design process. Relatively quickly, it became obvious that the spatial
clustering had to be explained to a broader audience that expected
static visualizations, in the style of biomedical illustrations. Future
works will stay closer to the illustrative style during the interactive
model development phase, to reduce the cost of later redesign.
L5. Build decision trees and conditionals to help explain spatial
cluster differences. When working with the broader audience, we
found that the easiest way to explain cluster differences required
explicit construction of decision trees, and ”conditionals” based
on the structure of the data—attempting to directly enocode the
differences was infeasible.
7 CONCLUSION
This work reflects on the process of designing visualizations for
clustering with anatomical spatial data. These designs were devel-
oped in two phases over several years, using participatory design
alongside collaborators with background in bioinformatics and ra-
diation oncology. Through these designs iterations, we distill a set
of lessons learned. While we focus on are particular problem, our
design approach can be generalized to other type of cancer with
spatially dependent data. These designs are part of a larger body of
work borne out of a multi-year collaboration with domain experts
with anatomical cancer data. By incorporating additional insights
from sibling projects, we aim to develop a comprehensive set of de-
sign guidelines for visualizing clusters of spatial data and effectively
disseminating these results to domain expert audiences outside of
the visualization community.
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